人类血清粉样蛋白A的新调控作用
Carlos G García-Cortés1, Elsie I Parés-Matos1
1Department of Chemistry, University of Puerto Rico at Mayagüez, CALL BOX 9000, Mayagüez, PR 00681-9000.
概括
血清粉样蛋白A (SAA) 是一种急性阶段蛋白质,与其他九种参与关键生物过程的蛋白质相互作用. 这些相互作用可能导致阿尔茨海默氏症和癌症等疾病.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 血清粉样蛋白A (SAA) 是一种关键的急性阶段蛋白质,参与炎症,瘤发生和压力.
- 了解SAA的蛋白质-蛋白质相互作用是阐明其多样化的生理作用的关键.
研究的目的:
- 为了识别和描述与血清粉样蛋白A (SAA) 相关的蛋白质复合体.
- 研究SAA相互作用对人类健康和疾病的功能影响.
主要方法:
- 利用HepG2细胞系用于SAA过度表达.
- 采用共免疫沉 (Co-IP) 和液体染色学-并联质谱法 (LC/MS/MS) 进行蛋白质复合体分析.
主要成果:
- 在诱导样本中证实SAA表达的显著上调.
- 鉴定了SAA的9种新型蛋白相互作用体,包括那些参与actin动力学,神经元形态发生,脂质平衡和免疫调节的蛋白相互作用体.
结论:
- SAA与细胞功能至关重要的蛋白质进行多种分子相互作用.
- 这些相互作用凸显了SAA在阿尔茨海默病,癌症和类风湿关节炎等病理方面的潜在作用.
- 为开发基于SAA的向治疗提供了基础.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K
Drug Binding to Blood Components
137
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
137
Regulation of Hormone Secretion
3.3K
Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral...
Humoral...
3.3K
Liver Physiology
489
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
489


